Toward Mechanistic Design of Surrogate Buffers for Dissolution Testing of pH-Dependent Drug Delivery Systems

被引:9
作者
Blechar, Johannes Andreas [1 ]
Al-Gousous, Jozef [1 ,2 ]
Wilhelmy, Christoph [1 ]
Postina, Annika Marielina [3 ]
Getto, Marcus [3 ]
Langguth, Peter [1 ]
机构
[1] Johannes Gutenberg Univ Mainz, Dept Biopharmaceut & Pharmaceut Technol, D-55099 Mainz, Germany
[2] Univ Michigan, Dept Pharmaceut Sci, Ann Arbor, MI 48104 USA
[3] Johannes Gutenberg Univ Mainz, Inst Pharmaceut & Biomed Sci, D-55099 Mainz, Germany
关键词
enteric coating; dissolution; bicarbonate; succinate; citrate; surrogate buffer; biorelevant; Eudragit; HPMCP; HPMCAS; BICARBONATE; DIFFUSION; TRANSPORT; PHOSPHATE; MODELS;
D O I
10.3390/pharmaceutics12121197
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The in vivo dissolution of enteric-coated (EC) products is often overestimated by compendial in vitro dissolution experiments. It is of great interest to mimic the in vivo conditions as closely as possible in vitro in order to predict the in vivo behavior of EC dosage forms. The reason behind this is the overly high buffering capacity of the common compendial buffers compared to the intestinal bicarbonate buffer. However, a bicarbonate-based buffer is technically difficult to handle due to the need for continuous sparging of the media with CO2 to maintain the desired buffer pH. Therefore, bicarbonate buffers are not commonly used in routine practice and a non-volatile alternative is of interest. A mathematical mass transport modelling approach was previously found to enable accurate calculation of surrogate buffer molarities for small molecule compounds; however, the additional complexity of polymeric materials makes this difficult to achieve for an enteric coat. In this work, an approach was developed allowing relatively rapid screening of potential surrogate buffers for enteric coating. It was found that the effective buffering pKa of bicarbonate at the surface of a dissolving enteric polymer tended to be around 5.5, becoming higher when the dissolving enteric polymer formed a gel of greater firmness/viscosity and vice versa. Using succinate (pKa 5.2 under physiological ionic strength) and/or citrate (pKa 5.7 under physiological ionic strength) at conjugate base molarities corresponding to bicarbonate molarities in the intestinal segments of interest as an initial "guess" can minimize the number of experimental iterations necessary to design an appropriate surrogate.
引用
收藏
页码:1 / 13
页数:13
相关论文
共 28 条
[1]   Mechanistic analysis and experimental verification of bicarbonate-controlled enteric coat dissolution: Potential in vivo implications [J].
Al-Gousous, J. ;
Ruan, H. ;
Blechar, J. A. ;
Sun, K. X. ;
Salehi, N. ;
Langguth, P. ;
Job, N. M. ;
Lipka, E. ;
Loebenberg, R. ;
Bermejo, M. ;
Amidon, G. E. ;
Amidon, G. L. .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2019, 139 :47-58
[2]   Toward Biopredictive Dissolution for Enteric Coated Dosage Forms [J].
Al-Gousous, J. ;
Amidon, G. L. ;
Langguth, P. .
MOLECULAR PHARMACEUTICS, 2016, 13 (06) :1927-1936
[3]   Mass Transport Analysis of Bicarbonate Buffer: Effect of the CO2-H2CO3 Hydration-Dehydration Kinetics in the Fluid Boundary Layer and the Apparent Effective pKa Controlling Dissolution of Acids and Bases [J].
Al-Gousous, Jozef ;
Salehi, Niloufar ;
Amidon, Gregory E. ;
Ziff, Robert M. ;
Langguth, Peter ;
Amidon, Gordon L. .
MOLECULAR PHARMACEUTICS, 2019, 16 (06) :2626-2635
[4]   Mass Transport Analysis of the Enhanced Buffer Capacity of the Bicarbonate-CO2 Buffer in a Phase-Heterogenous System: Physiological and Pharmaceutical Significance [J].
Al-Gousous, Jozef ;
Sun, Kathy X. ;
McNamara, Daniel P. ;
Hens, Bart ;
Salehi, Niloufar ;
Langguth, Peter ;
Bermejo, Marival ;
Amidon, Gregory E. ;
Amidon, Gordon L. .
MOLECULAR PHARMACEUTICS, 2018, 15 (11) :5291-5301
[5]   Unpredictable Performance of pH-Dependent Coatings Accentuates the Need for Improved Predictive in Vitro Test Systems [J].
Al-Gousous, Jozef ;
Tsume, Yasuhiro ;
Fu, Maoqi ;
Salem, Isam I. ;
Langguth, Peter .
MOLECULAR PHARMACEUTICS, 2017, 14 (12) :4209-4219
[6]   In vitro biorelevant models for evaluating modified release mesalamine products to forecast the effect of formulation and meal intake on drug release [J].
Andreas, Cord J. ;
Chen, Ying-Chen ;
Markopoulos, Constantinos ;
Reppas, Christos ;
Dressman, Jennifer .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2015, 97 :39-50
[7]   INTESTINAL FLUID AND ELECTROLYTE TRANSPORT IN HUMAN CHOLERA [J].
BANWELL, JG ;
PIERCE, NF ;
MITRA, RC ;
BRIGHAM, KL ;
CARANASOS, GJ ;
KEIMOWITZ, RI ;
FEDSON, DS ;
THOMAS, J ;
GORBACH, SL ;
SACK, RB ;
MONDAL, A .
JOURNAL OF CLINICAL INVESTIGATION, 1970, 49 (01) :183-+
[8]   CONTRIBUTION OF SCINTIGRAPHY TO VERIFY THE RELIABILITY OF DIFFERENT PREPARATION PROCESSES FOR ENTERIC-COATED CAPSULES [J].
CATTEAU, D ;
BARTHELEMY, C ;
DEVEAUX, M ;
ROBERT, H ;
TRUBLIN, F ;
MARCHANDISE, X ;
VANDRUNEN, H .
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1994, 19 (02) :91-98
[9]   Dissolution testing as a prognostic tool for oral drug absorption: Immediate release dosage forms [J].
Dressman, JB ;
Amidon, GL ;
Reppas, C ;
Shah, VP .
PHARMACEUTICAL RESEARCH, 1998, 15 (01) :11-22
[10]   Physiological bicarbonate buffers: stabilisation and use as dissolution media for modified release systems [J].
Fadda, Hala M. ;
Merchant, Hamid A. ;
Arafat, Basel T. ;
Basit, Abdul W. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2009, 382 (1-2) :56-60